Literature DB >> 28973482

High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.

Hao D Cheng1, Henning Stöckmann2, Barbara Adamczyk2, Ciara A McManus2, Altan Ercan3, Ingrid A Holm4, Pauline M Rudd2, Margaret E Ackerman1,5, Peter A Nigrovic3,6.   

Abstract

Juvenile idiopathic arthritis (JIA) encompasses all forms of chronic idiopathic arthritis that arise before age 16. Previous studies have found JIA to be associated with lower Fc galactosylation of circulating IgG, but the overall spectrum of glycan changes and the net impact on IgG function are unknown. Using ultra performance liquid chromatography (UPLC), we compared IgG glycosylation in 54 subjects with recent-onset untreated JIA with 98 healthy pediatric controls, paired to biophysical profiling of affinity for 20 IgG receptors using a high-throughput multiplexed microsphere assay. Patients with JIA exhibited an increase in hypogalactosylated and hyposialylated IgG glycans, but no change in fucosylation or bisection, together with alteration in the spectrum of IgG ligand binding. Supervised machine learning demonstrated a robust capacity to discriminate JIA subjects from controls using either glycosylation or binding data. The binding signature was driven predominantly by enhanced affinity for Fc receptor like protein 5 (FcRL5), a noncanonical Fc receptor expressed on B cells. Affinity for FcRL5 correlated inversely with galactosylation and sialylation, a relationship confirmed through enzymatic manipulation. These results demonstrate the capacity of combined structural and biophysical IgG phenotyping to define the overall functional impact of IgG glycan changes and implicate FcRL5 as a potential cellular sensor of IgG glycosylation.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  FcRL5; IgG glycan; IgG receptor binding; juvenile idiopathic arthritis; machine learning

Mesh:

Substances:

Year:  2017        PMID: 28973482      PMCID: PMC5881781          DOI: 10.1093/glycob/cwx082

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  80 in total

1.  The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjögren's syndrome (SS).

Authors:  A Bond; A Alavi; J S Axford; P Youinou; F C Hay
Journal:  Clin Exp Immunol       Date:  1996-07       Impact factor: 4.330

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

Review 3.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

4.  Highly parallel characterization of IgG Fc binding interactions.

Authors:  Austin W Boesch; Eric P Brown; Hao D Cheng; Maame Ofua Ofori; Erica Normandin; Peter A Nigrovic; Galit Alter; Margaret E Ackerman
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

5.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.

Authors:  Yuta Kochi; Ryo Yamada; Akari Suzuki; John B Harley; Senji Shirasawa; Tetsuji Sawada; Sang-Cheol Bae; Shinya Tokuhiro; Xiaotian Chang; Akihiro Sekine; Atsushi Takahashi; Tatsuhiko Tsunoda; Yozo Ohnishi; Kenneth M Kaufman; Changsoo Paul Kang; Changwon Kang; Shigeru Otsubo; Wako Yumura; Akio Mimori; Takao Koike; Yusuke Nakamura; Takehiko Sasazuki; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

Review 6.  Juvenile idiopathic arthritis.

Authors:  Berent Prakken; Salvatore Albani; Alberto Martini
Journal:  Lancet       Date:  2011-06-18       Impact factor: 79.321

7.  Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum.

Authors:  H Ulrich Scherer; Jun Wang; René E M Toes; Diane van der Woude; Carolien A M Koeleman; Arjen R de Boer; Tom W J Huizinga; André M Deelder; Manfred Wuhrer
Journal:  Proteomics Clin Appl       Date:  2008-11-20       Impact factor: 3.494

8.  Estrogens regulate glycosylation of IgG in women and men.

Authors:  Altan Ercan; Wendy M Kohrt; Jing Cui; Kevin D Deane; Marija Pezer; Elaine W Yu; Jonathan S Hausmann; Harry Campbell; Ursula B Kaiser; Pauline M Rudd; Gordan Lauc; James F Wilson; Joel S Finkelstein; Peter A Nigrovic
Journal:  JCI Insight       Date:  2017-02-23

9.  Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity.

Authors:  R B Parekh; I M Roitt; D A Isenberg; R A Dwek; B M Ansell; T W Rademacher
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

10.  Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome.

Authors:  Frano Vučković; Jasminka Krištić; Ivan Gudelj; Maria Teruel; Toma Keser; Marija Pezer; Maja Pučić-Baković; Jerko Štambuk; Irena Trbojević-Akmačić; Clara Barrios; Tamara Pavić; Cristina Menni; Youxin Wang; Yong Zhou; Liufu Cui; Haicheng Song; Qiang Zeng; Xiuhua Guo; Bernardo A Pons-Estel; Paul McKeigue; Alan Leslie Patrick; Olga Gornik; Tim D Spector; Miroslav Harjaček; Marta Alarcon-Riquelme; Mariam Molokhia; Wei Wang; Gordan Lauc
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

View more
  6 in total

1.  Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.

Authors:  Fabio Dall'Olio; Nadia Malagolini
Journal:  Exp Suppl       Date:  2021

Review 2.  Automation of Immunoglobulin Glycosylation Analysis.

Authors:  Jenifer L Hendel; Richard A Gardner; Daniel I R Spencer
Journal:  Exp Suppl       Date:  2021

Review 3.  Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective.

Authors:  Konstantinos Flevaris; Cleo Kontoravdi
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

Review 4.  Antibody glycosylation in autoimmune diseases.

Authors:  Xing Zhou; Francesca Motta; Carlo Selmi; William M Ridgway; M Eric Gershwin; Weici Zhang
Journal:  Autoimmun Rev       Date:  2021-03-14       Impact factor: 9.754

5.  Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor Profiles.

Authors:  Noortje de Haan; Maarten J D van Tol; Gertjan J Driessen; Manfred Wuhrer; Arjan C Lankester
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

Review 6.  Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases.

Authors:  Danqi Li; Yuchen Lou; Yamin Zhang; Si Liu; Jun Li; Juan Tao
Journal:  Theranostics       Date:  2021-03-13       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.